Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Application of Amyloid PET in Cerebral Amyloid Angiopathy
NCT03542656Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2014
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by National Taiwan University Hospital. Primary endpoint: PET imaging results at 3 days. Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT03542656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542656.